Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of the brain obstructed by seizures, these are categorized into generalized seizures and partial seizures. Generalized seizures affect the whole brain, while partial seizures affect just one part of the brain. Depending on their severity, seizures are termed as mild seizures and stronger seizures. Mild seizures are difficult to diagnose, as these last for only a few seconds. Stronger seizures may last for a few seconds to a few or several minutes, resulting in spasms and uncontrollable muscle twitches. This may cause the patient to lose consciousness, lead to temporary loss of cognition, or memory loss during the seizure. Pediatric epilepsy can be caused due to a trauma injury, complications during birth, or genetic disorder. Epilepsy that occurs due to brain infections such as meningitis is known as symptomatic epilepsy, while genetics related condition is called idiopathic epilepsy.
This report contains market size and forecasts of Anti-epileptic Drugs for Pediatrics in global, including the following market information:
Global Anti-epileptic Drugs for Pediatrics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-epileptic Drugs for Pediatrics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-epileptic Drugs for Pediatrics companies in 2021 (%)
The global Anti-epileptic Drugs for Pediatrics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1st Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-epileptic Drugs for Pediatrics include Mylan N.V, Cephalon, Inc, GlaxoSmithKline plc, Janssen Pharmaceuticals, Novartis AG, Pfizer, Inc, Sanofi S.A, UCB Pharma Limited and Sunovion Pharmaceuticals Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-epileptic Drugs for Pediatrics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-epileptic Drugs for Pediatrics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-epileptic Drugs for Pediatrics Market Segment Percentages, by Type, 2021 (%)
- 1st Generation
- 2nd Generation
- 3rd Generation
Global Anti-epileptic Drugs for Pediatrics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-epileptic Drugs for Pediatrics Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Retail Pharmacies
- Online Pharmacies
Global Anti-epileptic Drugs for Pediatrics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-epileptic Drugs for Pediatrics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-epileptic Drugs for Pediatrics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-epileptic Drugs for Pediatrics revenues share in global market, 2021 (%)
Key companies Anti-epileptic Drugs for Pediatrics sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-epileptic Drugs for Pediatrics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mylan N.V
- Cephalon, Inc
- GlaxoSmithKline plc
- Janssen Pharmaceuticals
- Novartis AG
- Pfizer, Inc
- Sanofi S.A
- UCB Pharma Limited
- Sunovion Pharmaceuticals Limited
- Valeant Pharmaceuticals International, Inc
- Zogenix
- GW Pharmaceuticals
- Insys
- Zynerba
Anti-epileptic Drugs for Pediatrics Market, Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Anti-epileptic Drugs for Pediatrics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-epileptic Drugs for Pediatrics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-epileptic Drugs for Pediatrics Overall Market Size
2.1 Global Anti-epileptic Drugs for Pediatrics Market Size: 2021 VS 2028
2.2 Global Anti-epileptic Drugs for Pediatrics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-epileptic Drugs for Pediatrics Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-epileptic Drugs for Pediatrics Players in Global Market
3.2 Top Global Anti-epileptic Drugs for Pediatrics Companies Ranked by Revenue
3.3 Global Anti-epileptic Drugs for Pediatrics Revenue by Companies
3.4 Global Anti-epileptic Drugs for Pediatrics Sales by Companies
3.5 Global Anti-epileptic Drugs for Pediatrics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-epileptic Drugs for Pediatrics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-epileptic Drugs for Pediatrics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-epileptic Drugs for Pediatrics Players in Global Market
3.8.1 List of Global Tier 1 Anti-epileptic Drugs for Pediatrics Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-epileptic Drugs for Pediatrics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-epileptic Drugs for Pediatrics Market Size Markets, 2021 & 2028
4.1.2 1st Generation
4.1.3 2nd Generation
4.1.4 3rd Generation
4.2 By Type - Global Anti-epileptic Drugs for Pediatrics Revenue & Forecasts
4.2.1 By Type - Global Anti-epileptic Drugs for Pediatrics Revenue, 2017-2022
4.2.2 By Type - Global Anti-epileptic Drugs for Pediatrics Revenue, 2023-2028
4.2.3 By Type - Global Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-epileptic Drugs for Pediatrics Sales & Forecasts
4.3.1 By Type - Global Anti-epileptic Drugs for Pediatrics Sales, 2017-2022
4.3.2 By Type - Global Anti-epileptic Drugs for Pediatrics Sales, 2023-2028
4.3.3 By Type - Global Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
4.4 By Type - Global Anti-epileptic Drugs for Pediatrics Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-epileptic Drugs for Pediatrics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Anti-epileptic Drugs for Pediatrics Revenue & Forecasts
5.2.1 By Application - Global Anti-epileptic Drugs for Pediatrics Revenue, 2017-2022
5.2.2 By Application - Global Anti-epileptic Drugs for Pediatrics Revenue, 2023-2028
5.2.3 By Application - Global Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-epileptic Drugs for Pediatrics Sales & Forecasts
5.3.1 By Application - Global Anti-epileptic Drugs for Pediatrics Sales, 2017-2022
5.3.2 By Application - Global Anti-epileptic Drugs for Pediatrics Sales, 2023-2028
5.3.3 By Application - Global Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
5.4 By Application - Global Anti-epileptic Drugs for Pediatrics Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-epileptic Drugs for Pediatrics Market Size, 2021 & 2028
6.2 By Region - Global Anti-epileptic Drugs for Pediatrics Revenue & Forecasts
6.2.1 By Region - Global Anti-epileptic Drugs for Pediatrics Revenue, 2017-2022
6.2.2 By Region - Global Anti-epileptic Drugs for Pediatrics Revenue, 2023-2028
6.2.3 By Region - Global Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-epileptic Drugs for Pediatrics Sales & Forecasts
6.3.1 By Region - Global Anti-epileptic Drugs for Pediatrics Sales, 2017-2022
6.3.2 By Region - Global Anti-epileptic Drugs for Pediatrics Sales, 2023-2028
6.3.3 By Region - Global Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anti-epileptic Drugs for Pediatrics Revenue, 2017-2028
6.4.2 By Country - North America Anti-epileptic Drugs for Pediatrics Sales, 2017-2028
6.4.3 US Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.4.4 Canada Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.4.5 Mexico Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anti-epileptic Drugs for Pediatrics Revenue, 2017-2028
6.5.2 By Country - Europe Anti-epileptic Drugs for Pediatrics Sales, 2017-2028
6.5.3 Germany Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5.4 France Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5.5 U.K. Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5.6 Italy Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5.7 Russia Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5.8 Nordic Countries Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.5.9 Benelux Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anti-epileptic Drugs for Pediatrics Revenue, 2017-2028
6.6.2 By Region - Asia Anti-epileptic Drugs for Pediatrics Sales, 2017-2028
6.6.3 China Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.6.4 Japan Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.6.5 South Korea Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.6.6 Southeast Asia Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.6.7 India Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anti-epileptic Drugs for Pediatrics Revenue, 2017-2028
6.7.2 By Country - South America Anti-epileptic Drugs for Pediatrics Sales, 2017-2028
6.7.3 Brazil Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.7.4 Argentina Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales, 2017-2028
6.8.3 Turkey Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.8.4 Israel Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
6.8.6 UAE Anti-epileptic Drugs for Pediatrics Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Mylan N.V
7.1.1 Mylan N.V Corporate Summary
7.1.2 Mylan N.V Business Overview
7.1.3 Mylan N.V Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.1.4 Mylan N.V Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.1.5 Mylan N.V Key News
7.2 Cephalon, Inc
7.2.1 Cephalon, Inc Corporate Summary
7.2.2 Cephalon, Inc Business Overview
7.2.3 Cephalon, Inc Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.2.4 Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.2.5 Cephalon, Inc Key News
7.3 GlaxoSmithKline plc
7.3.1 GlaxoSmithKline plc Corporate Summary
7.3.2 GlaxoSmithKline plc Business Overview
7.3.3 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.3.4 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline plc Key News
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Corporate Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.4.4 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.4.5 Janssen Pharmaceuticals Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.5.4 Novartis AG Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.5.5 Novartis AG Key News
7.6 Pfizer, Inc
7.6.1 Pfizer, Inc Corporate Summary
7.6.2 Pfizer, Inc Business Overview
7.6.3 Pfizer, Inc Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.6.4 Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer, Inc Key News
7.7 Sanofi S.A
7.7.1 Sanofi S.A Corporate Summary
7.7.2 Sanofi S.A Business Overview
7.7.3 Sanofi S.A Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.7.4 Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi S.A Key News
7.8 UCB Pharma Limited
7.8.1 UCB Pharma Limited Corporate Summary
7.8.2 UCB Pharma Limited Business Overview
7.8.3 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.8.4 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.8.5 UCB Pharma Limited Key News
7.9 Sunovion Pharmaceuticals Limited
7.9.1 Sunovion Pharmaceuticals Limited Corporate Summary
7.9.2 Sunovion Pharmaceuticals Limited Business Overview
7.9.3 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.9.4 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.9.5 Sunovion Pharmaceuticals Limited Key News
7.10 Valeant Pharmaceuticals International, Inc
7.10.1 Valeant Pharmaceuticals International, Inc Corporate Summary
7.10.2 Valeant Pharmaceuticals International, Inc Business Overview
7.10.3 Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.10.4 Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.10.5 Valeant Pharmaceuticals International, Inc Key News
7.11 Zogenix
7.11.1 Zogenix Corporate Summary
7.11.2 Zogenix Anti-epileptic Drugs for Pediatrics Business Overview
7.11.3 Zogenix Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.11.4 Zogenix Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.11.5 Zogenix Key News
7.12 GW Pharmaceuticals
7.12.1 GW Pharmaceuticals Corporate Summary
7.12.2 GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Business Overview
7.12.3 GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.12.4 GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.12.5 GW Pharmaceuticals Key News
7.13 Insys
7.13.1 Insys Corporate Summary
7.13.2 Insys Anti-epileptic Drugs for Pediatrics Business Overview
7.13.3 Insys Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.13.4 Insys Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.13.5 Insys Key News
7.14 Zynerba
7.14.1 Zynerba Corporate Summary
7.14.2 Zynerba Business Overview
7.14.3 Zynerba Anti-epileptic Drugs for Pediatrics Major Product Offerings
7.14.4 Zynerba Anti-epileptic Drugs for Pediatrics Sales and Revenue in Global (2017-2022)
7.14.5 Zynerba Key News
8 Global Anti-epileptic Drugs for Pediatrics Production Capacity, Analysis
8.1 Global Anti-epileptic Drugs for Pediatrics Production Capacity, 2017-2028
8.2 Anti-epileptic Drugs for Pediatrics Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-epileptic Drugs for Pediatrics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-epileptic Drugs for Pediatrics Supply Chain Analysis
10.1 Anti-epileptic Drugs for Pediatrics Industry Value Chain
10.2 Anti-epileptic Drugs for Pediatrics Upstream Market
10.3 Anti-epileptic Drugs for Pediatrics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-epileptic Drugs for Pediatrics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Anti-epileptic Drugs for Pediatrics in Global Market
Table 2. Top Anti-epileptic Drugs for Pediatrics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-epileptic Drugs for Pediatrics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-epileptic Drugs for Pediatrics Revenue Share by Companies, 2017-2022
Table 5. Global Anti-epileptic Drugs for Pediatrics Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-epileptic Drugs for Pediatrics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-epileptic Drugs for Pediatrics Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Anti-epileptic Drugs for Pediatrics Product Type
Table 9. List of Global Tier 1 Anti-epileptic Drugs for Pediatrics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-epileptic Drugs for Pediatrics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-epileptic Drugs for Pediatrics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-epileptic Drugs for Pediatrics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-epileptic Drugs for Pediatrics Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-epileptic Drugs for Pediatrics Sales (K Units), 2023-2028
Table 16. By Application - Global Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-epileptic Drugs for Pediatrics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-epileptic Drugs for Pediatrics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-epileptic Drugs for Pediatrics Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-epileptic Drugs for Pediatrics Sales (K Units), 2023-2028
Table 21. By Region - Global Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-epileptic Drugs for Pediatrics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-epileptic Drugs for Pediatrics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-epileptic Drugs for Pediatrics Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-epileptic Drugs for Pediatrics Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales, (K Units), 2023-2028
Table 46. Mylan N.V Corporate Summary
Table 47. Mylan N.V Anti-epileptic Drugs for Pediatrics Product Offerings
Table 48. Mylan N.V Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Cephalon, Inc Corporate Summary
Table 50. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 51. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. GlaxoSmithKline plc Corporate Summary
Table 53. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 54. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Janssen Pharmaceuticals Corporate Summary
Table 56. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product Offerings
Table 57. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Novartis AG Corporate Summary
Table 59. Novartis AG Anti-epileptic Drugs for Pediatrics Product Offerings
Table 60. Novartis AG Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Pfizer, Inc Corporate Summary
Table 62. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 63. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Sanofi S.A Corporate Summary
Table 65. Sanofi S.A Anti-epileptic Drugs for Pediatrics Product Offerings
Table 66. Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. UCB Pharma Limited Corporate Summary
Table 68. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Product Offerings
Table 69. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sunovion Pharmaceuticals Limited Corporate Summary
Table 71. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Product Offerings
Table 72. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Valeant Pharmaceuticals International, Inc Corporate Summary
Table 74. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 75. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Zogenix Corporate Summary
Table 77. Zogenix Anti-epileptic Drugs for Pediatrics Product Offerings
Table 78. Zogenix Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. GW Pharmaceuticals Corporate Summary
Table 80. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product Offerings
Table 81. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Insys Corporate Summary
Table 83. Insys Anti-epileptic Drugs for Pediatrics Product Offerings
Table 84. Insys Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Zynerba Corporate Summary
Table 86. Zynerba Anti-epileptic Drugs for Pediatrics Product Offerings
Table 87. Zynerba Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Anti-epileptic Drugs for Pediatrics Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Anti-epileptic Drugs for Pediatrics Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Anti-epileptic Drugs for Pediatrics Production by Region, 2017-2022 (K Units)
Table 91. Global Anti-epileptic Drugs for Pediatrics Production by Region, 2023-2028 (K Units)
Table 92. Anti-epileptic Drugs for Pediatrics Market Opportunities & Trends in Global Market
Table 93. Anti-epileptic Drugs for Pediatrics Market Drivers in Global Market
Table 94. Anti-epileptic Drugs for Pediatrics Market Restraints in Global Market
Table 95. Anti-epileptic Drugs for Pediatrics Raw Materials
Table 96. Anti-epileptic Drugs for Pediatrics Raw Materials Suppliers in Global Market
Table 97. Typical Anti-epileptic Drugs for Pediatrics Downstream
Table 98. Anti-epileptic Drugs for Pediatrics Downstream Clients in Global Market
Table 99. Anti-epileptic Drugs for Pediatrics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-epileptic Drugs for Pediatrics Segment by Type
Figure 2. Anti-epileptic Drugs for Pediatrics Segment by Application
Figure 3. Global Anti-epileptic Drugs for Pediatrics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-epileptic Drugs for Pediatrics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-epileptic Drugs for Pediatrics Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-epileptic Drugs for Pediatrics Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-epileptic Drugs for Pediatrics Revenue in 2021
Figure 9. By Type - Global Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-epileptic Drugs for Pediatrics Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-epileptic Drugs for Pediatrics Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 19. US Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 24. Germany Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 33. China Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 40. Brazil Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales Market Share, 2017-2028
Figure 44. Turkey Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-epileptic Drugs for Pediatrics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-epileptic Drugs for Pediatrics Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-epileptic Drugs for Pediatrics by Region, 2021 VS 2028
Figure 50. Anti-epileptic Drugs for Pediatrics Industry Value Chain
Figure 51. Marketing Channels
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
